TY  - JOUR
AU  - Bastidas, Adriana
AU  - de la Serna, Javier
AU  - El Idrissi, Mohamed
AU  - Oostvogels, Lidia
AU  - Quittet, Philippe
AU  - López-Jiménez, Javier
AU  - Vural, Filiz
AU  - Pohlreich, David
AU  - Zuckerman, Tsila
AU  - Issa, Nicolas C
AU  - Gaidano, Gianluca
AU  - Lee, Je-Jung
AU  - Abhyankar, Sunil
AU  - Solano, Carlos
AU  - Perez de Oteyza, Jaime
AU  - Satlin, Michael J
AU  - Schwartz, Stefan
AU  - Campins, Magda
AU  - Rocci, Alberto
AU  - Vallejo Llamas, Carlos
AU  - Lee, Dong-Gun
AU  - Tan, Sen Mui
AU  - Johnston, Anna M
AU  - Grigg, Andrew
AU  - Boeckh, Michael J
AU  - Campora, Laura
AU  - Lopez-Fauqued, Marta
AU  - Heineman, Thomas C
AU  - Stadtmauer, Edward A
AU  - Sullivan, Keith M
AU  - ZOE-HSCT Study Group Collaborators
PY  - 2019
DO  - 10.1001/jama.2019.9053
UR  - https://hdl.handle.net/10668/28445
T2  - JAMA
AB  - Herpes zoster, a frequent complication following autologous hematopoietic stem cell transplantation (HSCT), is associated with significant morbidity. A nonlive adjuvanted recombinant zoster vaccine has been developed to prevent posttransplantation...
LA  - en
KW  - Adjuvants, Immunologic
KW  - Adult
KW  - Female
KW  - Follow-Up Studies
KW  - Hematopoietic Stem Cell Transplantation
KW  - Herpes Zoster
KW  - Herpes Zoster Vaccine
KW  - Hospitalization
KW  - Humans
KW  - Immunocompromised Host
KW  - Incidence
KW  - Injections, Intramuscular
KW  - Male
KW  - Middle Aged
KW  - Neuralgia, Postherpetic
KW  - Proportional Hazards Models
KW  - Single-Blind Method
KW  - Transplantation, Autologous
KW  - Vaccines, Synthetic
TI  - Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.
TY  - research article
VL  - 322
ER  -